Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on March 23rd, 2012% Yonas Tadesse (University of Texas at Dallas)
Researchers at University of Texas at Dallas and Virginia Tech in Blacksburg have developed an autonomous undersea vehicle inspired by the common jellyfish that runs on hydrogen and oxygen in the water. The team, led by Dallas engineering professor and first author Yonas Tadesse (pictured left), . . . → Read More: Robot Jellyfish Runs on Hydrogen, Oxygen in Water
By Alan, on March 23rd, 2012% Virginia Tech in Blacksburg is setting up a new research center devoted to the study of vehicle tires. The Center for Tire Research, which will involve collaborations with other institutions and tire and auto companies, gets its initial funding from a National Science Foundation (NSF) grant.
The tire research center is expected to focus on . . . → Read More: Virginia Tech to Establish Auto Tire Research Center
By Alan, on March 23rd, 2012% (DigitalVision/NIEHS.gov)
The U.S. Food and Drug Administration approved the Linx Reflux Management System, a surgical implant device for people diagnosed with gastroesophageal reflux disease (GERD). The Linx system is made by Torax Medical Inc. in St. Paul, Minnesota.
GERD is a condition where the stomach contents leak backwards from the stomach into the . . . → Read More: FDA Approves Implanted Reflux Disease Treatment Device
By Alan, on March 23rd, 2012% Caroline Masiello (Rice University)
A research team at Rice University in Houston, Texas has found that heating biochar — charcoal added to topsoil to enhance plant growth — to 450 degrees Celsius increases its ability to deliver water and nutrients to the targeted crops. Their findings appear online this week in the journal . . . → Read More: Study Shows Increased Heat Boosts Biochar as Soil Additive
By Alan, on March 22nd, 2012% (National Institute of Mental Health)
Euthymics Bioscience Inc. in Cambridge, Massachusetts says it has started a phase 1 clinical trial of its drug candidate EB-1020 to treat attention deficit hyperactivity disorder (ADHD) in adults. The company says that EB-1020 is notable because it has a low risk of drug abuse liability, a problem . . . → Read More: Trial Underway for Non-Addictive ADHD Drug for Adults
By Alan, on March 22nd, 2012% Carbon nanotube illustration (National Science Foundation)
Engineers at University of Florida in Gainesville are investigating ways of reducing the toxicity of carbon nanotubes, a promising technology with applications in semiconductors, energy storage, and displays. The latest findings of environmental engineer Jean-Claude Bonzongo, chemical engineer Kirk Ziegler, and their Florida colleagues appear in the . . . → Read More: Aqueous Solution Tested to Reduce Carbon Nanotube Toxicity
By Alan, on March 22nd, 2012% Marco Santello (left) and students in his lab conduct experiments in sensory and cognitive abilities. (Jessica Slater, Arizona State Univ.)
Grants from the National Science Foundation will fund research into sensory and cognitive connections between the brain and the hands that can lead to new prosthetic devices and treatments. The NSF funds totaling . . . → Read More: Grants to Fund Brain-Hand Neural Connections Research
By Alan, on March 21st, 2012% National Institutes of Health
Research conducted by Scripps Research Institute in La Jolla, California discovered a potential biomarker found in a patient’s blood that can help predict if that person is at imminent risk of a heart attack. The findings of Scripps’s Eric Topol and colleagues appear in this week’s issue of the . . . → Read More: Blood Biomarker Can Help Predict Imminent Heart Attack Risks
By Alan, on March 21st, 2012% Figurine used in femto-photography experiments (MIT Media Lab)
Researchers at Massachusetts Institute of Technology, Harvard, and Rice University have devised a system that can produce recognizable 3-D images of objects outside of a camera’s line of sight. Their findings are described in this week’s issue of the journal Nature Communications (paid subscription required).
. . . → Read More: Camera Captures Photos of Objects Beyond Line of Sight
By Alan, on March 21st, 2012% (U.S. Mint)
The London-based venture capital company Index Ventures unveiled a new investment fund for early-stage life sciences companies, with pharmaceutical companies GlaxoSmithKline and Janssen, a division of Johnson & Johnson, among the investors. The Index Life VI fund, valued at €150 million ($US230 million), is the first for Index Ventures devoted solely . . . → Read More: GSK, Johnson & Johnson Join in Life Science Venture Fund
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.